| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/18/2009 | WO2009074518A1 Combinations of prolinamide p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009074305A1 Gold xanthogenates and medicaments comprising them |
| 06/18/2009 | WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 06/18/2009 | US20090156686 Composition containing higher fatty acid derivative and foods and drinks |
| 06/18/2009 | US20090156666 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/18/2009 | US20090156625 Novel Use of a Nicotinic Receptor Agonist 156 |
| 06/18/2009 | US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090156551 Novel composition |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155237 Compositions and methods for bone strengthening |
| 06/18/2009 | US20090155221 Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
| 06/18/2009 | US20090155216 Grafting Material and Agent for Improvement in bone Quality |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155200 Methods of promoting cartilage healing or cartilage integration |
| 06/18/2009 | CA2706811A1 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 06/18/2009 | CA2706658A1 Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition |
| 06/17/2009 | EP2071020A2 Tissue Implant |
| 06/17/2009 | EP2070948A1 Humanized Anti-CD4 antibody with immunosuppressive properties |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP2070927A1 Fused heterocyclic derivative |
| 06/17/2009 | EP2070924A1 New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070920A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 06/17/2009 | EP2070919A1 Spiroquinone compound and pharmaceutical composition |
| 06/17/2009 | EP2070914A1 New antagonist derivatives of the vitronectin receiver, method for preparing same, application of same as medicine and pharmaceutical compositions containing them |
| 06/17/2009 | EP2070541A1 Promoter of hard tissue regeneration |
| 06/17/2009 | EP2070525A1 Compositions comprising Magnolol and/or Honokiol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/17/2009 | EP2070524A1 Compositions comprising Magnolol and/or Honokiol and glucosamine and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/17/2009 | EP2070523A1 Composition comprising Magnolol and Honokiol in synergistic amount |
| 06/17/2009 | EP2069352A2 Certain chemical entities, compositions and methods |
| 06/17/2009 | EP2069342A1 2-aryl-6-phenylimidazo[1,2-alpha]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2069336A1 Pyridin-4-yl derivatives as immunomodulating agents |
| 06/17/2009 | EP2069335A1 Pyridin-3-yl derivatives as immunomodulating agents |
| 06/17/2009 | EP2069313A2 Metalloprotease inhibitors |
| 06/17/2009 | EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 06/17/2009 | EP1485381B1 Azolylaminoazine as inhibitors of protein kinases |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | EP1390408A4 A molecular marker |
| 06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
| 06/17/2009 | CN100500193C Extract from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | US7547680 Benzimidazole derivatives and medical uses thereof |
| 06/16/2009 | US7547453 Method of production of material for treating mammalian joint maladies by biological fluid transplantation |
| 06/16/2009 | CA2487365C Piperidine derivatives as potassium channel blockers |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2353063C Benzimidazole compounds that are vitronectin receptor antagonists |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2334877C Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 06/11/2009 | WO2009073300A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/11/2009 | WO2009073186A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | WO2009072626A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072578A1 Bone resorption inhibitor |
| 06/11/2009 | WO2009072576A1 Bone formation stimulator |
| 06/11/2009 | WO2009072527A1 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 06/11/2009 | WO2009072119A2 Amphiphilic peptide matrices for treatment of osteoporosis |
| 06/11/2009 | WO2009071707A1 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/11/2009 | WO2009071706A1 Pyrazolepyrimidine compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/11/2009 | WO2009071705A1 Pyrazolepyrimidine compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/11/2009 | WO2009071161A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | WO2002065984A3 Compounds having retinoid-like activity |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149539 Pet food compositions and methods |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149423 Use for a very low molecular weight heparins |
| 06/11/2009 | US20090149420 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090148489 Bioabsorbable material |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148436 Antibody to gdf8 and uses thereof |
| 06/11/2009 | CA2707663A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | CA2707585A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | CA2704266A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067480A1 Musclin receptor and use thereof |
| 06/10/2009 | EP2067477A1 New use of ginsenoside compound-k in manufacturing medicaments |
| 06/10/2009 | EP2066685A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 06/10/2009 | EP2066654A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 06/10/2009 | EP2066645A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 06/10/2009 | EP2066630A1 Piperidine derivatives |
| 06/10/2009 | EP1601673B1 Fused heterocycles and uses thereof |
| 06/10/2009 | EP1383869B1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | DE10143146B4 Antiarthrotische Zubereitung und deren Verwendung Antiarthrotische preparation and their use |
| 06/10/2009 | CN101454048A Sulphated hyaluronic acid for treating degenerative osteoarthritis |
| 06/10/2009 | CN101450950A Tetracyclic heterocompounds as estrogen receptor modulators |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |